Search Within

Gopakumar Vasudeva Iyer

  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (8)
  2. Meeting Abstract (6)
Groups
  1. Department of Medicine (14)
  2. Genitourinary Oncology Service (14)
  3. Molecular Imaging and Therapy Service (14)
  4. Solid Tumor Oncology Division (14)
  5. Human Oncology and Pathogenesis Program (9)
  6. Department of Pathology and Laboratory Medicine (8)

More Groups

People
  1. Jonathan Rosenberg (7)
  2. David Solit (6)
  3. Dean Bajorin (6)
  4. Hebert Vargas Alvarez (6)
  5. David Hyman (5)
  6. Hikmat Al-Ahmadie (5)

More People

Years
  1. 2025 (1)
  2. 2024 (1)
  3. 2023 (2)
  4. 2022 (1)
  5. 2021 (1)
  6. 2020 (1)

More Years

Publications
  1. Journal of Clinical Oncology (9)
  2. Cancer Chemotherapy and Pharmacology (1)
  3. Clinical Cancer Research (1)
  4. International Journal of Gynecological Cancer (1)
  5. Nature (1)
  6. Nature Communications (1)
Publishers
  1. American Society of Clinical Oncology (9)
  2. Nature Publishing Group (2)
  3. American Association for Cancer Research (1)
  4. Lippincott Williams & Wilkins (1)
  5. Springer (1)

Results (14)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Updated long-term follow-up from a phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Jayalath, V.; Teo, M. Y.; Assel, M.; Rodriguez, D.; Meyerson, A.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Associations of dietary fructose with survival of patients (pts) with metastatic cancer of the urothelium (UC) and renal cell carcinoma (RCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Badri, A.; Guercio, B. J.; Ratna, N.; Gavrilov, D.; Metzker, N.; Duzgol, C.; Teo, M. Y.; Regazzi, A. M.; Supplice, L.; Funt, S. A.; more...
    Journal of Clinical Oncology (2024)

    Fulltext@MSK | Save
  • Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Multicenter phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy for patients with high-grade upper tract urothelial carcinoma
    Journal Article

    Coleman, J. A.; Yip, W.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Cha, E. K.; Donahue, T. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Final results of a multicenter prospective phase II clinical trial of gemcitabine and cisplatin as neoadjuvant chemotherapy in patients with high-grade upper tract urothelial carcinoma
    Meeting Abstract

    Yip, W.; Coleman, J.; Wong, N. C.; Sjoberg, D. D.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Pietzak, E. J.; Hakimi, A. A.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase II clinical trial of everolimus in a pan-cancer cohort of patients with mTOR pathway alterations
    Journal Article

    Adib, E.; Klonowska, K.; Giannikou, K.; Do, K. T.; Pruitt-Thompson, S.; Bhushan, K.; Milstein, M. I.; Hedglin, J.; Kargus, K. E.; Sholl, L. M.; more...
    Clinical Cancer Research (2021)

    Fulltext@MSK | Save
  • Modeling biological and genetic diversity in upper tract urothelial carcinoma with patient derived xenografts
    Journal Article

    Kim, K.; Hu, W.; Audenet, F.; Almassi, N.; Hanrahan, A. J.; Murray, K.; Bagrodia, A.; Wong, N.; Clinton, T. N.; Dason, S.; more...
    Nature Communications (2020)

    Fulltext@MSK | Save
  • A multi-histology basket trial of ado-trastuzumab emtansine in patients with HER2 amplified cancers
    Meeting Abstract

    Li, B. T.; Makker, V.; Buonocore, D. J.; Offin, M. D.; Olah, Z. T.; Panora, E.; Shen, R.; Ho, A. L.; Yaeger, R.; Iyer, G.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • Multicenter prospective phase II trial of neoadjuvant dose-dense gemcitabine plus cisplatin in patients with muscle-invasive bladder cancer
    Journal Article

    Iyer, G.; Balar, A. V.; Milowsky, M. I.; Bochner, B. H.; Dalbagni, G.; Donat, S. M.; Herr, H. W.; Huang, W. C.; Taneja, S. S.; Woods, M.; more...
    Journal of Clinical Oncology (2018)

    Fulltext@MSK | Save
  • HER kinase inhibition in patients with HER2-and HER3-mutant cancers
    Journal Article

    Hyman, D. M.; Piha-Paul, S. A.; Won, H.; Rodon, J.; Saura, C.; Shapiro, G. I.; Juric, D.; Quinn, D. I.; Moreno, V.; Doger, B.; more...
    Nature (2018)

    Fulltext@MSK | Save